 |
eteplirsen |
|---|---|
| Trade Name | Exondys 51 |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2007-10-23 00:00:00 |
| Sponsor | Sarepta Therapeutics, Inc.;215 First Street, Suite 415;Cambridge, Massachusetts, 02142 |
| |
eteplirsen |
|---|---|
| Trade Name | Exondys 51 |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2007-10-23 00:00:00 |
| Sponsor | Sarepta Therapeutics, Inc.;215 First Street, Suite 415;Cambridge, Massachusetts, 02142 |